186 related articles for article (PubMed ID: 6871487)
1. Monoclonal antibodies in the diagnosis of epithelial premalignant lesions.
Dabelsteen E; Graem N; Hakomori S; Young WW
Bull Cancer; 1983; 70(2):127-31. PubMed ID: 6871487
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of a blood group antigen precursor in oral premalignant lesions.
Dabelsteen E; Vedtofte P; Hakomori S; Young WW
Cancer Res; 1983 Mar; 43(3):1451-4. PubMed ID: 6825113
[TBL] [Abstract][Full Text] [Related]
3. [Immunopathology of the oral mucosa. Oral immune system--inflammatory reactions--tumor-"marker"--virus identification].
Löning T
Veroff Pathol; 1984; 121():1-178. PubMed ID: 6322469
[TBL] [Abstract][Full Text] [Related]
4. Premalignant and malignant oral lesions are associated with changes in the glycosylation pattern of carbohydrates related to ABH blood group antigens.
Dabelsteen E; Clausen H; Holmstrup P; Reibel J
APMIS; 1988 Sep; 96(9):813-9. PubMed ID: 3048339
[TBL] [Abstract][Full Text] [Related]
5. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
6. Oncofetal fibronectins in oral carcinomas: correlation of two different types.
Mandel U; Gaggero B; Reibel J; Therkildsen MH; Dabelsteen E; Clausen H
APMIS; 1994 Sep; 102(9):695-702. PubMed ID: 7946273
[TBL] [Abstract][Full Text] [Related]
7. Epithelial isoantigens A, B and H in oral carcinomas.
Gupta YN; Gupta S; Singh IJ; Khanna NN; Agarwal MK
Ear Nose Throat J; 1985 May; 64(5):239-42. PubMed ID: 3996275
[No Abstract] [Full Text] [Related]
8. Langerhans cells in epithelial tumors and benign lesions of the oropharynx.
Girod SC; Kühnast T; Ulrich S; Krueger GR
In Vivo; 1994; 8(4):543-7. PubMed ID: 7893981
[TBL] [Abstract][Full Text] [Related]
9. ABH and related histo-blood group antigens in normal & malignant human endometrium in relation to genetic and hormonal factors.
Skovlund VR
APMIS Suppl; 1997; 69():1-33. PubMed ID: 9254838
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of oral premalignant and malignant lesions using cytomorphometry.
Ramaesh T; Mendis BR; Ratnatunga N; Thattil RO
Odontostomatol Trop; 1999 Mar; 22(85):23-8. PubMed ID: 11372099
[TBL] [Abstract][Full Text] [Related]
11. Exfoliative cytology in screening for malignant and premalignant lesions in the buccal mucosa.
Ramaesh T; Ratnatunga N; Mendis BR; Rajapaksa S
Ceylon Med J; 1998 Dec; 43(4):206-9. PubMed ID: 10355174
[TBL] [Abstract][Full Text] [Related]
12. Changes in the glycosylation pattern of histo-blood group antigens in benign, premalignant and malignant laryngeal epithelial lesions.
Stenersen TC; Dabelsteen E
APMIS Suppl; 1992; 27():139-48. PubMed ID: 1520523
[TBL] [Abstract][Full Text] [Related]
13. Premalignant oral mucosal diseases.
Melrose RJ
J Calif Dent Assoc; 2001 Aug; 29(8):593-600. PubMed ID: 11577670
[TBL] [Abstract][Full Text] [Related]
14. Altered distribution and synthesis of laminin-5 (kalinin) in oral lichen planus, epithelial dysplasias and squamous cell carcinomas.
Kainulainen T; Autio-Harmainen H; Oikarinen A; Salo S; Tryggvason K; Salo T
Br J Dermatol; 1997 Mar; 136(3):331-6. PubMed ID: 9115910
[TBL] [Abstract][Full Text] [Related]
15. Advances in the diagnosis of oral premalignant and malignant lesions.
Epstein JB; Zhang L; Rosin M
J Can Dent Assoc; 2002 Nov; 68(10):617-21. PubMed ID: 12410942
[TBL] [Abstract][Full Text] [Related]
16. Pathology of malignant and premalignant oral epithelial lesions.
Greer RO
Otolaryngol Clin North Am; 2006 Apr; 39(2):249-75, v. PubMed ID: 16580910
[TBL] [Abstract][Full Text] [Related]
17. p53 immunoexpression in non-malignant oral mucosa adjacent to oral squamous cell carcinoma: potential consequences for clinical management.
Cruz IB; Meijer CJ; Snijders PJ; Snow GB; Walboomers JM; van Der Waal I
J Pathol; 2000 Jun; 191(2):132-7. PubMed ID: 10861571
[TBL] [Abstract][Full Text] [Related]
18. Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice.
Epstein JB; Sciubba J; Silverman S; Sroussi HY
Head Neck; 2007 Oct; 29(10):948-58. PubMed ID: 17764090
[TBL] [Abstract][Full Text] [Related]
19. Desmosomes and gap junctions in precarcinomatous and carcinomatous conditions of squamous epithelia. An electron microscopic and morphometrical study.
Kocher O; Amaudruz M; Schindler AM; Gabbiani G
J Submicrosc Cytol; 1981 Apr; 13(2):267-81. PubMed ID: 7338968
[TBL] [Abstract][Full Text] [Related]
20. Histopathologic evaluation of proliferating cell nuclear antigen (PC10) in oral epithelial hyperplasias and premalignant lesions.
Huang WY; Coltrera M; Schubert M; Morton T; Truelove E
Oral Surg Oral Med Oral Pathol; 1994 Dec; 78(6):748-54. PubMed ID: 7534896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
